Hasegawa, Y <br/><br/>
The competitive NMDA antagonist MDL-100,453 reduces infarct size after experimental stroke.  [electronic resource] 

 -  Stroke  Jun 1994 
 - 1241-4; discussion 1245-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0039-2499 
<br/><br/><label>Standard No.: </label>10.1161/01.str.25.6.1241  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Pressure--physiology<br/>Body Temperature--drug effects<br/>Brain--drug effects<br/>Carbon Dioxide--blood<br/>Cerebral Arteries<br/>Cerebral Infarction--blood<br/>Infusion Pumps<br/>Injections, Intravenous<br/>Ischemic Attack, Transient--blood<br/>Male<br/>N-Methylaspartate--administration & dosage<br/>Pilot Projects<br/>Placebos<br/>Rats<br/>Rats, Sprague-Dawley<br/>Valine--administration & dosage